Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Manufacturing
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Reset
1 / 44
1 / 44
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03
July 22, 2024
CRDO
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
Silvia Steyrer-Gruber
Coriolis Pharma
PAO-07-24-CL-05
July 16, 2024
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-07
July 16, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-06
July 16, 2024
Biosimilars
Navigating the Global Regulatory Landscape for Biosimilars
Veronica Grimoldi
Biosidus
PAO-07-24-CL-09
July 16, 2024
Chronic Diseases
Transforming the Management of Chronic Diseases with Biosimilars
Hugo Sotelo; Jorge Catella
Biosidus
PAO-07-24-CL-10
July 16, 2024
Liquid Suspensions
Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations
Gus LaBella
Mikart
PAO-07-24-CL-04
July 09, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01
July 02, 2024
Synthetic DNA
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Tom Merritt, Ph.D.
Touchlight
PAO-07-24-CL-01
July 02, 2024
Digitalization
Overcoming Development Challenges with Digital Solutions
Wheeler Bio
PAO-06-24-CL-06
July 02, 2024
Trusted Partnerships
Partnerships for Success
Ryan Lee
Samsung Biologics
PAO-06-24-CL-08
June 25, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02
June 18, 2024
Training
Biotech Training is a Challenge
April Stanley, MS MBA; Koey Keylon
PAO-06-24-NI-01
June 11, 2024
mRNA Innovations
Technology Advances Needed to Drive Future mRNA Growth
Hagen Richter, Ph.D.
PAO-04-24-CL-04
April 15, 2024
ESG
Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report
PCI Pharma Services
PR-M03-24-04
March 27, 2024
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
April Stanley, MS MBA
PAO-03-24-NI-02
March 27, 2024
Lead Share Agreement
List Biotherapeutics and Sacco System Announce Lead Share Agreement
List Bio
PR-M03-24-03
March 14, 2024
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
Xuemei Han, Ph.D.
Tanvex CDMO
PAO-03-24-CL-09
March 13, 2024
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
Dongyoung Park
Samsung Biologics
PAO-03-24-CL-01
March 04, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09
February 26, 2024